Nephrology Principal Investigators

Basic Research Investigators

Edward Y. Skolnik, MD: Signal Transduction Mechanisms, Autosomal Dominant Polycystic Kidney Disease, T-lymphocyte activation

Clinical Research Investigators

PI Olga Zhdanova: A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (s12-03333), The Nephrotic Syndrome Study Network (08-940),
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis (DUET)
(S14-00443)

David S. Goldfarb, MD: A Therapeutic-Equivalence Study Comparing the Efficacy and Safety of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients with Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment (VA 01308), Blood Volume Analysis and Related Outcomes in Hemodialysis (VA 01249), The Rare Kidney Stones Consortium (RKSC) - Cystinuria Registry (09-0425), The Rare Kidney Stones Consortium (RKSC) – Biobank (s12-03113), The Rare Kidney Stones Consortium (RKSC) - Quality of Life Assessment in Rare Kidney Stones (S13-00968), Night-time use of thiazide diuretics for improved reduction in stone risk in stone formers with elevated urine calcium (VA 01417)

Lada Beara-Lasic, MD:
 Dent Disease RegistryRole of phosphorus and FGF 23 in patients with Dent diseaseA Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)

Jerome Lowenstein, MD: The secretion of Glutamine in Chronic Renal AcidosisThe Effect of an antibiotic on the production of uremic toxin: a pilot studyThe Effects of Uremic toxins on Gene expression in cultured human renal tubular cells

Olga Zhdanova, MD: A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental GlomerulosclerosisTHE NEPHROTIC SYNDROME STUDY NETWORK (NEPTUNE)

Lois Katz, MD: Systolic Blood Pressure Interventional Trial SPRINT  (10-07) , ACCORD Follow-On Study (ACCORDION) -- Health Related Quality of Life and Cost Effectiveness Substudies (01269) 

Nephrology Fellows

Fellows Research 2013

Fellows Research 2012

Fellows Research 2011